SCHEMBL2564083

SCHEMBL2564083

Cc1cccc(CC2CCCN2C(=O)COCC2CCCCN2S(=O)(=O)c2c(Cl)cccc2Cl)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.35
ATM Q13315 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
JAK3 P52333 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
HTT P42858 1/20 0.34
RORC P51449 1/20 0.34
HSD11B1 P28845 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CASP3 P42574 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2570935 0.99 TP53 (0.36) TP53ATMJAK2JAK1JAK3
SCHEMBL2567373 0.91 RORC (0.36) TP53ATMMEN1KMT2ASMN1; SMN2
SCHEMBL2566400 0.88 RAB9A (0.40) TP53ATMSMN1; SMN2RAB9AALDH1A1
SCHEMBL2564067 0.85 MEN1 (0.40) MEN1KMT2ASMN1; SMN2RAB9AALDH1A1
SCHEMBL2566344 0.84 PAX8 (0.41) ATMCASP3CASP7PSEN1PSEN2
SCHEMBL2569764 0.78 KMT2A (0.44) MEN1KMT2ASMN1; SMN2RAB9AALDH1A1
SCHEMBL2569132 0.78 HCRTR1 (0.47) KMT2AALDH1A1LMNARORCNPSR1
SCHEMBL2570824 0.78 POLB (0.46) ALDH1A1LMNAUSP2HTT
SCHEMBL2566990 0.78 OPRK1 (0.36) ATMMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL5132594 0.77 ATM (0.46) ATMCASP3CASP7PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066659-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-08-28 EP claimed
EP-2383267-A1 Substituted sulfonamide derivatives Grünenthal GmbH (DE) 2011-11-02 EP claimed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US claimed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US claimed
EP-2066659-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-08-28 EP disclosed
US-8435978-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-05-07 US disclosed
US-20100324009-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-23 US disclosed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US disclosed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317644-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 TP53 2982/4885ATM 3057/4885JAK2 849/4885
US-20100324009-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 TP53 2982/4885ATM 3057/4885JAK2 849/4885
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 TP53 2982/4885ATM 3057/4885JAK2 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.